Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Statin use and cancer risk in the General Practice Research Database.

Kaye JA, Jick H.

Br J Cancer. 2004 Feb 9;90(3):635-7.

2.

Statin use and the risk of bladder cancer: a population-based case-control study.

Kuo CC, Chiu HF, Lee IM, Kuo HW, Lee CT, Yang CY.

Expert Opin Drug Saf. 2012 Sep;11(5):733-8. doi: 10.1517/14740338.2012.712960.

PMID:
22849562
3.

Statins increase the risk of prostate cancer: a population-based case-control study.

Chang CC, Ho SC, Chiu HF, Yang CY.

Prostate. 2011 Dec;71(16):1818-24. doi: 10.1002/pros.21401.

PMID:
21480313
4.

Statins and prostate cancer risk: a case-control study.

Shannon J, Tewoderos S, Garzotto M, Beer TM, Derenick R, Palma A, Farris PE.

Am J Epidemiol. 2005 Aug 15;162(4):318-25.

5.

Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans.

Marelli C, Gunnarsson C, Ross S, Haas S, Stroup DF, Cload P, Clopton P, DeMaria AN.

J Am Coll Cardiol. 2011 Jul 26;58(5):530-7. doi: 10.1016/j.jacc.2011.04.015.

6.

Exposure to statins and risk of common cancers: a series of nested case-control studies.

Vinogradova Y, Coupland C, Hippisley-Cox J.

BMC Cancer. 2011 Sep 26;11:409. doi: 10.1186/1471-2407-11-409.

7.

Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study.

Lustman A, Nakar S, Cohen AD, Vinker S.

Prostate Cancer Prostatic Dis. 2014 Mar;17(1):6-9. doi: 10.1038/pcan.2013.34.

PMID:
24061633
8.

Selectively increased risk of cancer in men with coronary heart disease.

Reicher-Reiss H, Jonas M, Goldbourt U, Boyko V, Modan B.

Am J Cardiol. 2001 Feb 15;87(4):459-62, A6.

PMID:
11179536
9.

Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.

Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C.

Arch Gen Psychiatry. 2007 Dec;64(12):1368-76.

PMID:
18056544
10.

Nationwide study of cancer risk among hip replacement patients in Sweden.

Signorello LB, Ye W, Fryzek JP, Lipworth L, Fraumeni JF Jr, Blot WJ, McLaughlin JK, Nyrén O.

J Natl Cancer Inst. 2001 Sep 19;93(18):1405-10.

11.

Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.

Pawlish KS, Schottenfeld D, Severson R, Montie JE.

Prostate. 1997 Oct 1;33(2):75-86.

PMID:
9316648
12.

Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.

Jick SS, Choi H, Li L, McInnes IB, Sattar N.

Ann Rheum Dis. 2009 Apr;68(4):546-51. doi: 10.1136/ard.2008.091967.

PMID:
18662929
13.

Risk of cancer after herpes zoster: a population-based study.

Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO.

N Engl J Med. 1982 Aug 12;307(7):393-7.

PMID:
6979711
14.

Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.

Koro C, Barrett S, Qizilbash N.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):485-92.

PMID:
17192841
15.

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2226-32.

16.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

17.

Statin use and risk of prostate cancer in a population of men who underwent biopsy.

Tan N, Klein EA, Li J, Moussa AS, Jones JS.

J Urol. 2011 Jul;186(1):86-90. doi: 10.1016/j.juro.2011.03.004.

PMID:
21571344
18.

Coffee and tea consumption and cancers of the bladder, colon and rectum.

Woolcott CG, King WD, Marrett LD.

Eur J Cancer Prev. 2002 Apr;11(2):137-45.

PMID:
11984131
19.

Risk of prostate and bladder cancers in patients with spinal cord injury: a population-based cohort study.

Lee WY, Sun LM, Lin CL, Liang JA, Chang YJ, Sung FC, Kao CH.

Urol Oncol. 2014 Jan;32(1):51.e1-7. doi: 10.1016/j.urolonc.2013.07.019.

PMID:
24239459
20.

Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.

Björkhem-Bergman L, Backheden M, Söderberg Löfdal K.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1101-6. doi: 10.1002/pds.3685.

PMID:
25074765
Items per page

Supplemental Content

Support Center